{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:04:30Z","timestamp":1789362270880,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Despite advances in treatment, small cell lung cancer (SCLC) remains highly aggressive and prone to relapse, leading to poor patient outcomes. Histone HIST1H4L is a key protein that maintains chromatin structure, but its role in SCLC is still unclear. This study aims to define its oncogenic role in SCLC and to determine whether it drives malignant progression by activating the PI3K\/AKT signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Public datasets were used to integrate HIST1H4L expression with differentially expressed genes. Functional bioinformatics investigations and survival association analyses were then conducted. Additionally, stable HIST1H4L knockdown cell lines were generated. Knockdown efficiency was confirmed at the mRNA and protein levels by qRT-PCR and Western blot (WB). Cell proliferation was measured using CCK-8 and EdU staining. Cell invasion was assessed with Transwell assays. Cellular senescence and apoptosis were evaluated by \u03b2-galactosidase staining and flow cytometry, respectively. Finally, WB was used to detect changes in key proteins of the PI3K\/AKT signaling pathway after HIST1H4L knockdown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HIST1H4L was significantly upregulated in SCLC tumors versus normal tissues and enriched in DNA transcription-related pathways. Critically, high HIST1H4L expression correlated with poor patient survival. HIST1H4L knockdown markedly suppressed proliferation, migration, and invasion. It also reduced senescence and apoptosis. HIST1H4L knockdown weakened the activation of the PI3K\/AKT signaling pathway. The levels of p-AKT and p-PI3K decreased, while total AKT and PI3K levels remained unchanged.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HIST1H4L is significantly overexpressed in SCLC and correlates with poor prognosis. It functions as a key oncogenic driver by activating the PI3K\/AKT pathway, promoting tumor proliferation and invasion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1959848","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:34:14Z","timestamp":1789360454000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["HIST1H4L promotes small cell lung cancer tumorigenesis by regulating the PI3K\/Akt pathway and serves as a potential diagnostic biomarker"],"prefix":"10.3389","volume":"16","author":[{"given":"Shicheng","family":"Feng","sequence":"first","affiliation":[{"name":"Radiotherapy Department, Zhongda Hospital, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, Zhongda Hospital, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, Zhongda Hospital, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[{"name":"Radiology Department, The Affiliated Brain Hospital of Nanjing Medical University [Chest Area]","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Hematology & Oncology, Jurong Hospital Affiliated to Jiangsu University","place":["Zhenjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.3390\/biomedicines11071982","article-title":"Small cell lung carcinoma: Current diagnosis, biomarkers, and treatment options with future perspectives","volume":"11","author":"Krpina","year":"2023","journal-title":"Biomedicines"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2025.100799","article-title":"Epidemiology of SCLC in the United States from 2000 to 2019: A study utilizing the Surveillance, Epidemiology, and End Results Registry","volume":"6","author":"Wells","year":"2025","journal-title":"JTO Clin Res Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.05.004","article-title":"Small cell lung cancer: Novel treatments beyond immunotherapy","volume":"86","author":"Meijer","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/cancers17020255","article-title":"Recent advances in the clinical translation of small-cell lung cancer therapeutics","volume":"17","author":"Das","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2022.103301","article-title":"Histone variants: The unsung guardians of the genome","volume":"112","author":"Phillips","year":"2022","journal-title":"DNA Repair (Amst)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1042\/BST20210567","article-title":"Histone mutations in cancer","volume":"51","author":"Espinoza Pereira","year":"2023","journal-title":"Biochem Soc Trans"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.661381","article-title":"The study of alternative splicing events in human induced pluripotent stem cells from a Down's syndrome patient","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24382","article-title":"RAGE is a potential biomarker implicated in immune infiltrates and cellular senescence in lung adenocarcinoma","volume":"36","author":"Lin","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049819","article-title":"Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma","volume":"7","author":"Camoes","year":"2012","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801073105","article-title":"Microsatellites as EWS\/FLI response elements in Ewing's sarcoma","volume":"105","author":"Gangwal","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7150\/jca.92899","article-title":"Illuminating shared genetic associations between oesophageal carcinoma and pulmonary carcinoma risk","volume":"15","author":"Zhang","year":"2024","journal-title":"J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2174\/1386207325666220427121619","article-title":"Identification of six novel prognostic gene signatures as potential biomarkers in small cell lung cancer","volume":"26","author":"Feng","year":"2023","journal-title":"Comb Chem High Throughput Screen"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12032-025-02718-0","article-title":"Mechanism of etoposide resistance in small cell lung cancer and the potential therapeutic options","volume":"42","author":"Fan","year":"2025","journal-title":"Med Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature09639","article-title":"Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma","volume":"469","author":"Varela","year":"2011","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nature08658","article-title":"A comprehensive catalogue of somatic mutations from a human cancer genome","volume":"463","author":"Pleasance","year":"2010","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.05.015","article-title":"Senescence in cancer","volume":"43","author":"Colucci","year":"2025","journal-title":"Cancer Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01070","article-title":"Targeting the PI3K\/AKT\/mTOR signaling pathway in the treatment of human diseases: Current status, trends, and solutions","volume":"65","author":"Huang","year":"2022","journal-title":"J Med Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3892\/br.2024.1918","article-title":"Mechanism of PI3K\/Akt-mediated mitochondrial pathway in obesity-induced apoptosis (Review)","volume":"22","author":"Li","year":"2025","journal-title":"BioMed Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8826","article-title":"Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation","volume":"7","author":"Fiorentino","year":"2016","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.17935","article-title":"Adenylate kinase 2 promotes tumor progression in small-cell lung cancer via PI3K\/AKT\/mTOR signaling","volume":"46","author":"Kim","year":"2026","journal-title":"Anticancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2025.04.021","article-title":"Corrigendum to \"PI3K\/Akt\/mTOR signaling orchestrates the phenotypic transition and chemo-resistance of small cell lung cancer\" [J. Genet. Genom. (2021) 48, 640-651","volume":"52","author":"Li","year":"2025","journal-title":"J Genet Genomics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2012.02.021","article-title":"The PI3K\/AKT\/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation","volume":"48","author":"Ettl","year":"2012","journal-title":"Oral Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.588200","article-title":"Prognostic role of the activated p-AKT molecule in various hematologic Malignancies and solid tumors: A meta-analysis","volume":"10","author":"Yao","year":"2020","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101316RR","article-title":"Co-culture with chorionic villous mesenchymal stem cells promotes endothelial cell proliferation and angiogenesis via ABCA9-AKT pathway","volume":"36","author":"Chu","year":"2022","journal-title":"FASEB J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/15330338251412203","article-title":"CCT3 facilitates the Malignant progression of NSCLC and SCLC via PI3 K\/AKT-EMT axis and emerges as a novel serum diagnostic biomarker","volume":"25","author":"Song","year":"2026","journal-title":"Technol Cancer Res Treat"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-024-01245-w","article-title":"Small cell lung cancer-an update on chemotherapy resistance","volume":"25","author":"Ying","year":"2024","journal-title":"Curr Treat Options Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00914-x","article-title":"Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer","volume":"21","author":"Sen","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.01.012","article-title":"Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.3390\/ijms25084208","article-title":"Transitioning to a personalized approach in molecularly subtyped small-cell lung cancer (SCLC)","volume":"25","author":"Grenda","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273445","article-title":"The value of artificial intelligence in the diagnosis of lung cancer: A systematic review and meta-analysis","volume":"18","author":"Liu","year":"2023","journal-title":"PloS One"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1959848\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:34:15Z","timestamp":1789360455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1959848\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":34,"alternative-id":["10.3389\/fonc.2026.1959848"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1959848","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1959848"}}